The human proton-coupled folate transporter (hPCFT): Modulation of intestinal expression and function by drugs

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 298, Issue 2, 2010, Pages

  Urquhart, Bradley L ^a,b   Gregor, Jamie C ^a   Chande, Nilesh ^a   Knauer, Michael J ^a,b   Tirona, Rommel G ^a,b   Kim, Richard B ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

Folic acid absorption; Vitamin

Indexed keywords

CARRIER PROTEIN; FOLIC ACID; METHOTREXATE; PROTON COUPLED FOLATE TRANSPORTER; PROTON PUMP INHIBITOR; PYRIMETHAMINE; SALAZOSULFAPYRIDINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTESTINE BIOPSY; INTESTINE CELL; MALE; PRIORITY JOURNAL;

ANIMALS; BIOPSY; CELL LINE; COLON; DOGS; DUODENUM; ENTEROCYTES; FOLIC ACID; FOLIC ACID ANTAGONISTS; HUMANS; ILEUM; INTESTINAL MUCOSA; KIDNEY; MEMBRANE TRANSPORT PROTEINS; METHOTREXATE; PROTON PUMP INHIBITORS; RNA, MESSENGER; TRANSFECTION; TRITIUM;

EID: 76749135846     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00224.2009     Document Type: Article

References (29)

1. Cheng Y, Prussoff WH. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22: 3099-3108, 1973.
2. DeWolfe J. Folate intake of older adults before and after fortification of grain products. Can J Diet Pract Res 68: 218-220, 2007.
3. Elsborg L, Larsen L. Folate deficiency in chronic inflammatory bowel diseases. Scand J Gastroenterol 14: 1019-1024, 1979.
4. Hepner GW, Booth CC, Cowan J, Hoffbrand AV, Mollin DL. Absorption of crystalline folic acid in man. Lancet 2: 302-306, 1968.
5. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 285: 2981-2986, 2001.
6. Inoue K, Nakai Y, Ueda S, Kamigaso S, Ohta KY, Hatakeyama M, Hayashi Y, Otagiri M, Yuasa H. Functional characterization of PCFT/ HCP1 as the molecular entity of the carrier-mediated intestinal folate transport system in the rat model. Am J Physiol Gastrointest Liver Physiol 294: G660-G668, 2008.
7. Jundt JW, Browne BA, Fiocco GP, Steele AD, Mock D. A comparison of low dose methotrexate bioavailability: oral solution, oral tablet, subcutaneous and intramuscular dosing. J Rheumatol 20: 1845-1849, 1993.
8. Kitis G, Lucas ML, Bishop H, Sargent A, Schneider RE, Blair JA, Allan RN. Altered jejunal surface pH in coeliac disease: its effect on propranolol and folic acid absorption. Clin Sci (Lond) 63: 373-380, 1982.
9. Krogh JM, Ekelund S, Svendsen L. Folate and homocysteine status and haemolysis in patients treated with sulphasalazine for arthritis. Scand J Clin Lab Invest 56: 421-429, 1996.
10. Kurnik D, Loebstein R, Fishbein E, Almog S, Halkin H, Bar-Meir S, Chowers Y. Bioavailability of oral vs. subcutaneous low-dose methotrexate in patients with Crohn's disease. Aliment Pharmacol Ther 18: 57-63, 2003.
11. Lambie DG, Johnson RH. Drugs and folate metabolism. Drugs 30: 145-155, 1985.
12. Laurence KM, James N, Miller MH, Tennant GB, Campbell H. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br Med J (Clin Res Ed) 282: 1509-1511, 1981.
13. Min SH, Oh SY, Karp GI, Poncz M, Zhao R, Goldman ID. The clinical course and genetic defect in the PCFT gene in a 27-year-old woman with hereditary folate malabsorption. J Pediatr 153: 435-437, 2008.
14. Nakai Y, Inoue K, Abe N, Hatakeyama M, Ohta KY, Otagiri M, Hayashi Y, Yuasa H. Functional characterization of human protoncoupled folate transporter/heme carrier protein 1 heterologously expressed in mammalian cells as a folate transporter. J Pharmacol Exp Ther 322: 469-476, 2007.
15. Qiu A, Jansen M, Sakaris A, Min SH, Chattopadhyay S, Tsai E, Sandoval C, Zhao R, Akabas MH, Goldman ID. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell 127: 917-928, 2006.
16. Qiu A, Min SH, Jansen M, Malhotra U, Tsai E, Cabelof DC, Matherly LH, Zhao R, Akabas MH, Goldman ID. Rodent intestinal folate transporters (SLC46A1): secondary structure, functional properties, and response to dietary folate restriction. Am J Physiol Cell Physiol 293: C1669-C1678, 2007.
17. Ray JG, Meier C, Vermeulen MJ, Boss S, Wyatt PR, Cole DE. Association of neural tube defects and folic acid food fortification in Canada. Lancet 360: 2047-2048, 2002.
18. Russell RM, Dhar GJ, Dutta SK, Rosenberg IH. Influence of intraluminal pH on folate absorption: studies in control subjects and in patients with pancreatic insufficiency. J Lab Clin Med 93: 428-436, 1979.
19. Russell RM, Golner BB, Krasinski SD, Sadowski JA, Suter PM, Braun CL. Effect of antacid and H2 receptor antagonists on the intestinal absorption of folic acid. J Lab Clin Med 112: 458-463, 1988.
20. Selhub J. Folate, vitamin B12 and vitamin B6 and one carbon metabolism. J Nutr Health Aging 6: 39-42, 2002.
21. Shayeghi M, Latunde-Dada GO, Oakhill JS, Laftah AH, Takeuchi K, Halliday N, Khan Y, Warley A, McCann FE, Hider RC, Frazer DM, Anderson GJ, Vulpe CD, Simpson RJ, McKie AT. Identification of an intestinal heme transporter. Cell 122: 789-801, 2005.
22. Sierra EE, Goldman ID. Characterization of folate transport mediated by a low pH route in mouse L1210 leukemia cells with defective reduced folate carrier function. Biochem Pharmacol 55: 1505-1512, 1998.
23. Steger GG, Mader RM, Vogelsang H, Schofl R, Lochs H, Ferenci P. Folate absorption in Crohn's disease. Digestion 55: 234-238, 1994.
24. Subramanian VS, Marchant JS, Said HM. Apical membrane targeting and trafficking of the human proton-coupled transporter in polarized epithelia. Am J Physiol Cell Physiol 294: C233-C240, 2008.
25. Sun JH, Das KM. Low-dose oral methotrexate for maintaining Crohn's disease remission: where we stand. J Clin Gastroenterol 39: 751-756, 2005.
26. Zhao R, Min SH, Qiu A, Sakaris A, Goldberg GL, Sandoval C, Malatack JJ, Rosenblatt DS, Goldman ID. The spectrum of mutations in the PCFT gene, coding for an intestinal folate transporter, that are the basis for hereditary folate malabsorption. Blood 110: 1147-1152, 2007.
27. Zhao R, Qiu A, Tsai E, Jansen M, Akabas MH, Goldman ID. The proton-coupled folate transporter: impact on pemetrexed transport and on antifolates activities compared with the reduced folate carrier. Mol Pharmacol 74: 854-862, 2008.
28. Zimmerman J, Gilula Z, Selhub J, Rosenberg IH. Kinetic analysis of the effect of luminal pH on transport of folic acid in the small intestine. Int J Vitam Nutr Res 59: 151-156, 1989.
29. Zimmerman J, Selhub J, Rosenberg IH. Competitive inhibition of folate absorption by dihydrofolate reductase inhibitors, trimethoprim and pyrimethamine. Am J Clin Nutr 46: 518-522, 1987.